In 2015, the UK became the first country in the world to have a comprehensive routine meningococcal vaccine programme targeting all of the main capsular groups of N. meningitidis. 1 An infant vaccine programme against meningococcal capsular group B Neisseria meningitidis (MenB) was launched from 1st September with an aim to reduce endemic MenB disease in early childhood. On 1st August 2015, an adolescent programme against groups A, C, W and Y meningococci (MenACWY) was rolled out to halt a growing outbreak of capsular group W disease (MenW) caused by a hypervirulent clone of N. meningitidis, in addition to maintaining control against MenC disease provided by the current adolescent programme. 2.

Original publication

DOI

10.1136/archdischild-2015-308928

Type

Journal article

Journal

Arch Dis Child

Publication Date

01/2016

Volume

101

Pages

91 - 95

Keywords

Immunisation, Infectious Diseases, Adolescent, Age Distribution, Child, Child, Preschool, England, Humans, Immunization Programs, Infant, Infant, Newborn, Meningococcal Infections, Meningococcal Vaccines, United Kingdom, Vaccines, Conjugate, Young Adult